Liptruzet (ezetimibe recalls
The FDA has published 4 recalls involving Liptruzet (ezetimibe since 2014. The latest was reported on 14 May 2014. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 14 May 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 4 100%
Why liptruzet (ezetimibe is recalled
Companies
By year
All liptruzet (ezetimibe recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg recalled | Merck | Other | Nationwide |
| Drug | CLASS III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/10 mg recalled | Merck | Packaging Defects | Nationwide |
| Drug | CLASS III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg recalled | Merck | Packaging Defects | Nationwide |
| Drug | CLASS III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/40 mg recalled | Merck | Packaging Defects | Nationwide |
Should you stop taking Liptruzet (ezetimibe?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.